References - Homocysteine in Protein Structure/Function and Human Disease - page 136

101. Lee JS, Kang Decker N, Chatterjee S, Yao J, Friedman S, Shah V. Mechanisms of nitric oxide
interplay with Rho GTPase family members in modulation of actin membrane dynamics in
pericytes and fibroblasts. Am J Pathol. 2005;166(6):1861-70.
102. Mudd SH, Finkelstein JD, Refsum H, Ueland PM, Malinow MR, Lentz SR, et al. Homocys-
teine and its disulfide derivatives: a suggested consensus terminology. Arterioscler Thromb
Vasc Biol. 2000;20(7):1704-6.
103. Refsum H, Helland S, Ueland PM. Radioenzymic determination of homocysteine in plasma
and urine. Clin Chem. 1985;31(4):624-8.
104. Sass JO, Nakanishi T, Sato T, Sperl W, Shimizu A. S-homocysteinylation of transthyretin is
detected in plasma and serum of humans with different types of hyperhomocysteinemia.
Biochem Biophys Res Commun. 2003;310(1):242-6.
105. Lim A, Sengupta S, McComb ME, Theberge R, Wilson WG, Costello CE, et al. In vitro and
in vivo interactions of homocysteine with human plasma transthyretin. J Biol Chem.
2003;278(50):49707-13.
106. Hortin GL, Seam N, Hoehn GT. Bound homocysteine, cysteine, and cysteinylglycine distri-
bution between albumin and globulins. Clin Chem. 2006;52(12):2258-64.
107. Eagle H, Oyama VI, Piez KA. The reversible binding of half-cystine residues to serum
protein, and its bearing on the cystine requirement of cultured mammalian cells. J Biol
Chem. 1960;235:1719-26.
108. King TP. On the sulfhydryl group of human plasma albumin. J Biol Chem. 1961;236:PC5.
109. Malloy MH, Rassin DK, Gaull GE. A method for measurement of free and bound plasma cyst
(e)ine. Anal Biochem. 1981;113(2):407-15.
110. Hanyu N, Shimizu T, Yamauchi K, Okumura N, Hidaka H. Characterization of cysteine and
homocysteine bound to human serum transthyretin. Clin Chim Acta. 2009;403(1-2):70-5.
111. Mansoor MA, Svardal AM, Ueland PM. Determination of the in vivo redox status of cysteine,
cysteinylglycine, homocysteine, and glutathione in human plasma. Anal Biochem. 1992;200
(2):218-29.
112. Muscat JE, Kleinman W, Colosimo S, Muir A, Lazarus P, Park J, et al. Enhanced protein
glutathiolation and oxidative stress in cigarette smokers. Free Radic Biol Med. 2004;36
(4):464-70.
113. Jakubowski H, Perla-Kajan J, Finnell RH, Cabrera RM, Wang H, Gupta S, et al. Genetic or
nutritional disorders in homocysteine or folate metabolism increase protein N-homocystei-
nylation in mice. FASEB J. 2009;23(6):1721-7.
114. Svardal A, Refsum H, Ueland PM. Determination of in vivo protein binding of homocysteine
and its relation to free homocysteine in the liver and other tissues of the rat. J Biol Chem.
1986;261(7):3156-63.
115. Jakubowski H, Boers GH, Strauss KA. Mutations in cystathionine {beta}-synthase or
methylenetetrahydrofolate reductase gene increase N-homocysteinylated protein levels in
humans. FASEB J. 2008;22(12):4071-6.
116. Kerins DM, Koury MJ, Capdevila A, Rana S, Wagner C. Plasma S-adenosylhomocysteine is
a more sensitive indicator of cardiovascular disease than plasma homocysteine. Am J Clin
Nutr. 2001;74(6):723-9.
117. Stabler SP, Allen RH. Quantification of serum and urinary S-adenosylmethionine and
S-adenosylhomocysteine by stable-isotope-dilution liquid chromatography-mass spectrome-
try. Clin Chem. 2004;50(2):365-72.
118. Maclean KN, Sikora J, Kozich V, Jiang H, Greiner LS, Kraus E, et al. Cystathionine beta-
synthase null homocystinuric mice fail to exhibit altered hemostasis or lowering of plasma
homocysteine in response to betaine treatment. Mol Genet Metab. 2010;101(2-3):163-71.
119. Quinn CT, Griener JC, Bottiglieri T, Hyland K, Farrow A, Kamen BA. Elevation of
homocysteine and excitatory amino acid neurotransmitters in the CSF of children who
receive methotrexate for the treatment of cancer. J Clin Oncol. 1997;15(8):2800-6.
120. Omori S, Kodama H, Ikegami T, Mizuhara S, Oura T. Unusual sulfur-containing amino acids
in the urine of homocystinuric patients: III. Homocysteic acid, homocysteine sulfinic acid,